Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,597,455
-
Share change
-
+417,664
-
Total reported value
-
$6,415,433,594
-
Put/Call ratio
-
71%
-
Price per share
-
$111.41
-
Number of holders
-
469
-
Value change
-
+$58,344,093
-
Number of buys
-
229
-
Number of sells
-
208
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2024
As of 30 Sep 2024,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
469 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,597,455 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., LSV ASSET MANAGEMENT, Pacer Advisors, Inc., STATE STREET CORP, Capital World Investors, DIMENSIONAL FUND ADVISORS LP, EcoR1 Capital, LLC, JPMORGAN CHASE & CO, and AMERIPRISE FINANCIAL INC.
This page lists
469
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.